PBE · Invesco

Invesco Biotechnology & Genome ETF

See how 33 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 30 April 2026Price US$95.07 as of 2 October 2026Holdings available · disclosure too old for reliability

Holdings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Core valuation

Trailing P/E44.27×100.00% coverage

Latest-quarter run-rate P/E48.46×100.00% coverage

Trailing P/S5.12×100.00% coverage

Latest-quarter run-rate P/S4.90×100.00% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.07% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

Largest reported ETF holdings with weights and trailing valuation ratios
Holding	Weight	Trailing P/E	Trailing P/S
UTHRUnited Therapeutics Corp.	6.28%	18.69×	7.77×
ILMNIllumina, Inc.	5.37%	48.63×	8.93×
BIIBBiogen Inc.	5.05%	23.98×	3.31×
INCYIncyte Corp.	4.91%	16.35×	4.37×
ALNYAlnylam Pharmaceuticals, Inc.	4.84%	39.93×	6.44×
REGNRegeneron Pharmaceuticals, Inc.	4.77%	17.99×	5.01×
AMGNAmgen Inc.	4.71%	25.18×	5.78×
GILDGilead Sciences, Inc.	4.62%	-56.45×	6.00×
BCRXBioCryst Pharmaceuticals, Inc.	3.42%	-5.39×	2.21×
CPRXCatalyst Pharmaceuticals, Inc.	3.30%	17.41×	6.46×

Top 10 of 33 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

IBBQ · Invesco Nasdaq Biotechnology ETF100.00% holdings overlap · US market
FBT · First Trust NYSE Arca Biotechnology Index Fund44.83% holdings overlap · NYSE Arca
BBH · VanEck Biotech ETF36.07% holdings overlap · Nasdaq
IBB · iShares Biotechnology ETF32.73% holdings overlap · US market
FTXH · First Trust Nasdaq Pharmaceuticals ETF30.64% holdings overlap · Nasdaq

Sources and limitations

Holdings are sourced from Invesco and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 30 April 2026. Informational research, not investment advice.